JT
Jorna Therapeutics utilizes Quantum Sky's AI to design DNARNA editors, enabling the development of novel treatments for genetic disorders that were previously unattainable. This technology addresses the need for precise and effective therapeutic solutions in the field of genetic medicine.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Jorna Therapeutics utilizes Quantum Sky's AI to design DNARNA editors, enabling the development of novel treatments for genetic disorders that were previously unattainable. This technology addresses the need for precise and effective therapeutic solutions in the field of genetic medicine.